# | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
---|---|---|---|---|---|---|---|---|---|
1. | ALA3296817 | F | Anticancer against human ER-positive MDA-MB-231 cells assessed as cell viability after 48 hrs by SRB assay | Homo sapiens | 7 | cell-based format | Scientific Literature | ||
2. | ALA3296818 | F | Anticancer against human ER-positive MCF7L cells assessed as cell viability after 48 hrs by SRB assay | Homo sapiens | 7 | assay format | Scientific Literature | ||
3. | ALA3296819 | F | Anticancer against human ER-positive MCF7 cells assessed as cell viability after 48 hrs by SRB assay | Homo sapiens | 7 | cell-based format | Scientific Literature | ||
4. | ALA3296820 | F | Anticancer against human ER-negative AU565 cells assessed as cell viability after 48 hrs by SRB assay | Homo sapiens | 7 | cell-based format | Scientific Literature | ||
5. | ALA3296826 | F | Anticancer against human HepG2 cells assessed as cell viability after 48 hrs by SRB assay | Homo sapiens | 6 | cell-based format | Scientific Literature | ||
6. | ALA3296827 | F | Anticancer against human Hepa1-6 cells assessed as cell viability after 48 hrs by SRB assay | Homo sapiens | 6 | cell-based format | Scientific Literature | ||
7. | ALA3296828 | F | Anticancer against human Hep3B cells assessed as cell viability after 48 hrs by SRB assay | Homo sapiens | 6 | cell-based format | Scientific Literature | ||
8. | ALA3296829 | F | Anticancer against human HeLa cells assessed as cell viability after 48 hrs by SRB assay | Homo sapiens | 6 | cell-based format | Scientific Literature | ||
9. | ALA3296830 | F | Anticancer against human HT-29 cells assessed as cell viability after 48 hrs by SRB assay | Homo sapiens | 6 | cell-based format | Scientific Literature | ||
10. | ALA3296831 | F | Anticancer against human HepG2 cells assessed as reduction in cell viability at 10 uM after 48 hrs by SRB assay | Homo sapiens | 2 | cell-based format | Scientific Literature |